Los Angeles Capital Management & Equity Research Inc. lessened its position in Natus Medical Incorporated (NASDAQ:BABY) by 50.2% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 16,818 shares of the medical equipment provider’s stock after selling 16,960 shares during the period. Los Angeles Capital Management & Equity Research Inc. owned about 0.05% of Natus Medical worth $631,000 as of its most recent filing with the SEC.

Several other large investors have also recently modified their holdings of the company. Eqis Capital Management Inc. lifted its position in Natus Medical by 25.0% during the 3rd quarter. Eqis Capital Management Inc. now owns 16,740 shares of the medical equipment provider’s stock valued at $628,000 after purchasing an additional 3,353 shares during the period. Bank of New York Mellon Corp increased its stake in shares of Natus Medical by 9.7% in the 2nd quarter. Bank of New York Mellon Corp now owns 973,346 shares of the medical equipment provider’s stock valued at $36,307,000 after acquiring an additional 86,192 shares during the last quarter. Virginia Retirement Systems ET AL increased its stake in shares of Natus Medical by 122.3% in the 2nd quarter. Virginia Retirement Systems ET AL now owns 26,900 shares of the medical equipment provider’s stock valued at $1,003,000 after acquiring an additional 14,800 shares during the last quarter. Great West Life Assurance Co. Can increased its stake in shares of Natus Medical by 3.0% in the 2nd quarter. Great West Life Assurance Co. Can now owns 48,240 shares of the medical equipment provider’s stock valued at $1,796,000 after acquiring an additional 1,383 shares during the last quarter. Finally, Municipal Employees Retirement System of Michigan increased its stake in shares of Natus Medical by 3.2% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 7,760 shares of the medical equipment provider’s stock valued at $289,000 after acquiring an additional 240 shares during the last quarter. Institutional investors own 94.35% of the company’s stock.

Natus Medical Incorporated (BABY) traded down $0.50 during trading hours on Friday, reaching $40.05. The company’s stock had a trading volume of 313,300 shares, compared to its average volume of 386,887. Natus Medical Incorporated has a 52-week low of $31.65 and a 52-week high of $43.60. The company has a current ratio of 4.21, a quick ratio of 3.36 and a debt-to-equity ratio of 0.36. The firm has a market cap of $1,247.72, a P/E ratio of 25.84 and a beta of 0.89.

Natus Medical (NASDAQ:BABY) last released its quarterly earnings results on Wednesday, October 25th. The medical equipment provider reported $0.40 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.02. Natus Medical had a positive return on equity of 12.06% and a negative net margin of 0.62%. The firm had revenue of $122.60 million during the quarter, compared to the consensus estimate of $122.41 million. During the same quarter in the prior year, the firm posted $0.39 EPS. The business’s revenue was up 34.9% on a year-over-year basis. research analysts forecast that Natus Medical Incorporated will post 1.74 EPS for the current year.

A number of research firms recently issued reports on BABY. BidaskClub cut Natus Medical from a “sell” rating to a “strong sell” rating in a research note on Thursday, August 24th. Zacks Investment Research raised Natus Medical from a “hold” rating to a “buy” rating and set a $45.00 target price for the company in a research note on Tuesday, October 24th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company. Natus Medical currently has an average rating of “Hold” and an average target price of $46.50.

In other Natus Medical news, Director Robert A. Gunst sold 4,400 shares of the firm’s stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $35.17, for a total transaction of $154,748.00. Following the completion of the sale, the director now owns 50,850 shares of the company’s stock, valued at approximately $1,788,394.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Dong Chune Christopher Chung sold 12,642 shares of the stock in a transaction on Monday, November 6th. The stock was sold at an average price of $42.91, for a total value of $542,468.22. Following the transaction, the vice president now owns 141,414 shares in the company, valued at approximately $6,068,074.74. The disclosure for this sale can be found here. In the last three months, insiders sold 22,042 shares of company stock valued at $902,266. 5.50% of the stock is currently owned by insiders.

COPYRIGHT VIOLATION NOTICE: This story was posted by Daily Political and is the property of of Daily Political. If you are reading this story on another website, it was illegally copied and republished in violation of US and international copyright and trademark laws. The original version of this story can be accessed at https://www.dailypolitical.com/2017/12/01/natus-medical-incorporated-baby-stake-lowered-by-los-angeles-capital-management-equity-research-inc.html.

Natus Medical Profile

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.

Institutional Ownership by Quarter for Natus Medical (NASDAQ:BABY)

Receive News & Ratings for Natus Medical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.